{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:43:01Z","timestamp":1791546181861,"version":"4.3.4"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T00:00:00Z","timestamp":1441238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Troponin elevation is common in acute heart failure (AHF) and may be useful for prognostication; however, available data are mixed and many previous studies used older, less sensitive assays. We examined the association between serial measurements of high-sensitivity cardiac troponin T (hs-cTnT) and outcomes in RELAX-AHF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Hs-cTnT was measured at baseline and days 2, 5, and 14. We assessed the relationship between baseline, peak and peak change hs-cTnT with dyspnoea relief by visual analogue scale, cardiovascular death, or HF\/renal hospitalization to 60\u2009days and cardiovascular mortality to 180\u2009days. Models were adjusted for clinical variables and treatment assignment. Whether baseline troponin status affected the treatment effect of serelaxin was assessed using interactions terms. In 1074 patients, the median baseline troponin was 0.033\u2009\u00b5g\/L, and 90% of patients were above the 99th upper reference limit (URL). Patients with hs-cTnT &amp;gt;median were more likely to be men with ischaemic heart disease, worse renal function, and higher N-terminal pro-brain natriuretic peptide. Higher baseline or peak hs-cTnT and greater peak change were associated with worse outcomes independent of adjustment for covariates, but relationships were generally strongest for 180-day cardiovascular mortality (hazard ratio per doubling of baseline hs-cTnT\u2009=\u20091.36, 95% confidence interval 1.15\u20131.60). Troponin was most strongly associated with death from heart failure or from other cardiovascular causes. The treatment effect of serelaxin did not differ by baseline troponin levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Hs-cTnT was elevated above the 99% URL in the majority of AHF patients. Baseline, peak, and peak change hs-cTnT were associated with worse outcomes, with the strongest relationship with 180-day cardiovascular mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ejhf.341","type":"journal-article","created":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T02:33:23Z","timestamp":1441247603000},"page":"1262-1270","source":"Crossref","is-referenced-by-count":128,"title":["Serial High Sensitivity Cardiac Troponin T Measurement in Acute Heart Failure: Insights from the Relax-Ahf Study"],"prefix":"10.1093","volume":"17","author":[{"given":"G. Michael","family":"Felker","sequence":"first","affiliation":[{"name":"Duke Clinical Research Institute , DUMC Box 3850, Durham, NC, 27710 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Mentz","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute , DUMC Box 3850, Durham, NC, 27710 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Teerlink","sequence":"additional","affiliation":[{"name":"University of California-San Francisco and San Francisco Veterans Affairs Medical Center , San Francisco, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan A.","family":"Voors","sequence":"additional","affiliation":[{"name":"University of Groningen , Groningen ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Pang","sequence":"additional","affiliation":[{"name":"Indiana University School of Medicine , Indianapolis, IN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[{"name":"Medical University, Clinical Military Hospital , Wroclaw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry H.","family":"Greenberg","sequence":"additional","affiliation":[{"name":"University of California San Diego , La Jolla, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos","family":"Filippatos","sequence":"additional","affiliation":[{"name":"Athens University Hospital , Attikon, Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth A.","family":"Davison","sequence":"additional","affiliation":[{"name":"Momentum Research Inc. , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gad","family":"Cotter","sequence":"additional","affiliation":[{"name":"Momentum Research Inc. , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret F.","family":"Prescott","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation , East Hanover, NJ ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsushung A.","family":"Hua","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation , East Hanover, NJ ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Lopez-Pintado","sequence":"additional","affiliation":[{"name":"Columbia University , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Severin","sequence":"additional","affiliation":[{"name":"Novartis Pharma AG , Basel ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Metra","sequence":"additional","affiliation":[{"name":"University of Brescia , Brescia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,9,3]]},"reference":[{"key":"2026011921102995100_ejhf341-bib-0001","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jacc.2010.06.016","article-title":"Troponin elevation in heart failure: prevalence, mechanisms, and clinical implications","volume":"56","author":"Kociol","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026011921102995100_ejhf341-bib-0002","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/CIRCHEARTFAILURE.111.961581","article-title":"Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study","volume":"4","author":"O\u2019Connor","year":"2011","journal-title":"Circ Heart Fail"},{"key":"2026011921102995100_ejhf341-bib-0003","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa0706824","article-title":"Cardiac troponin and outcome in acute heart failure","volume":"358","author":"Peacock","year":"2008","journal-title":"N Engl J Med"},{"key":"2026011921102995100_ejhf341-bib-0004","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/eurjhf\/hfs110","article-title":"Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study","volume":"14","author":"Felker","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026011921102995100_ejhf341-bib-0005","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ahj.2011.10.009","article-title":"Design of the RELAXin in acute heart failure study","volume":"163","author":"Ponikowski","year":"2012","journal-title":"Am Heart J"},{"key":"2026011921102995100_ejhf341-bib-0006","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","article-title":"Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial","volume":"381","author":"Teerlink","year":"2013","journal-title":"Lancet"},{"key":"2026011921102995100_ejhf341-bib-0007","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jacc.2012.11.005","article-title":"Effect of Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) Development Program: Correlation With Outcomes","volume":"61","author":"Metra","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026011921102995100_ejhf341-bib-0008","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.jacc.2014.05.071","article-title":"Effect of serelaxin on mode of death in acute heart failure: results from the RELAX-AHF study","volume":"64","author":"Felker","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026011921102995100_ejhf341-bib-0009","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ejheart.2007.05.007","article-title":"The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T","volume":"9","author":"Metra","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"2026011921102995100_ejhf341-bib-0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1071-9164(03)00594-3","article-title":"Serial measure of cardiac troponin T levels for prediction of clinical events in decompensated heart failure","volume":"10","author":"Del Carlo","year":"2004","journal-title":"J Card Fail"},{"key":"2026011921102995100_ejhf341-bib-0011","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ahj.2007.01.027","article-title":"Relation between cardiac troponin I and mortality in acute decompensated heart failure","volume":"153","author":"You","year":"2007","journal-title":"Am Heart J"},{"key":"2026011921102995100_ejhf341-bib-0012","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/eurjhf\/hfr047","article-title":"Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure","volume":"13","author":"Pascual-Figal","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026011921102995100_ejhf341-bib-0013","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/CIRCHEARTFAILURE.109.893222","article-title":"Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward","volume":"3","author":"Felker","year":"2010","journal-title":"Circ Heart Fail"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fejhf.341","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/17\/12\/1262\/66423204\/eurjhf_17_12_1262.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/17\/12\/1262\/66423204\/eurjhf_17_12_1262.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:11:05Z","timestamp":1768875065000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/17\/12\/1262\/8426403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,3]]},"references-count":13,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,9,3]]},"published-print":{"date-parts":[[2015,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.341","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,12]]},"published":{"date-parts":[[2015,9,3]]}}}